Off the wire
• Cambodian protesters attack police, injuring 2 officers  • Roundup: 1 out of 10 S. Korean companies becomes chronic "zombie": report  • Japan approves "hamburger" design for 2020 Olympics' main stadium  • China Focus: Post 80s consumers critical in economic transition toward consumption  • 1st LD Writethru: 2 killed when plane crashes in Indian capital  • 6 killed in eastern Afghan clash  • Yearender: China's free trade strategy takes shape with new agreements with S. Korea, Australia entering into force  • 1 out of 10 S. Korean companies becomes chronic "zombie": report  • Panama Canal expansion on track to complete in April 2016  • Brazilian president urges LatAm to settle political differences, bolster cooperation  
You are here: 　 Home

S. Korea's full recovery rate of cancer reaches 70 percent

Xinhua, December 22, 2015 Adjust font size:

More than two out of three cancer patients in South Korea made a full recovery from the fatal disease thanks to developed medical science and advanced screening system, a government report said Tuesday.

The rate of cancer patients surviving for more than five years, which means a de-facto complete recovery, reached 69.4 percent during the five-year period from 2009 to 2013, according to the Ministry of Health and Welfare.

It was up a whopping 15.6 percentage points from 53.8 percent tallied during the 2001-2005 period.

The higher survival rate was attributed to advanced medical science and early diagnosis through regular checkups as well as behavior to live a healthy life. A rising number of South Korean men quits smoking, contributing to the higher survival rate.

The highest rate of surviving for more than five years was thyroid cancer with 100.2 percent. It means that thyroid cancer patients even had a higher rate of survival than non-cancer patients.

More than 90 percent of patients diagnosed with prostate and breast cancers were completely healed during the cited five-year period, while more than 70 percent of colorectal and gastric cancer patients won a permanent cure.

However, the survival rates for patients diagnosed with pancreatic, lung and liver cancers were relatively low at 9.4 percent, 23.5 percent and 31.4 percent respectively.

The number of new cancer patients reached 225,343 in 2013, down from 226,216 a year earlier. It marked the first reduction since the related data began to be compiled in 1999.

The cancer incidence rate, which gauges the number of new cancer patient per 100,000 people, was 311.6 in 2013, down from 322.3 in 2012. Enditem